The France Journal
SEE OTHER BRANDS

The top news stories from France

The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on May 5, 2025

Do No Harm to Screen at Cannes Film Festival as Part of Iris Indie Global’s Bold 2025 Slate

Do No Harm to Screen at Cannes Film Festival as Part of Iris Indie Global’s Bold 2025 Slate

A searing psychological thriller spotlighting the mental health crisis in nursing, premiering on the world stage. LOS ANGELES, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Iris Indie Global announced today that the emotionally gripping thriller …

 Cannes 2025: Love Me Dead Starring RJ Mitte and Dove Cameron to Screen at the Marche du Film

Cannes 2025: Love Me Dead Starring RJ Mitte and Dove Cameron to Screen at the Marche du Film

The film has its U.S. Theatrical Release Slotted for August 8, 2025. LOS ANGELES, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- Love Me Dead, the darkly elegant thriller from GVN Releasing, will screen at the 2025 Marché du Film on Sunday, May 18 …

AgileOne Recognized as Top Global MSP Provider by HRO Today

AgileOne Recognized as Top Global MSP Provider by HRO Today

AgileOne is honored to share that the company has been selected as the top global Managed Service Provider (MSP) by HRO Today. TORRANCE, CA, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- AgileOne is honored to share that the company has been selected …

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

DBV Technologies to Participate in the Citizens JMP Life Sciences Conference

Châtillon, France, May 5, 2025 DBV Technologies to Participate in the Citizens JMP Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced …

DBV Technologies participera à la conférence Citizens JMP Life Sciences

DBV Technologies participera à la conférence Citizens JMP Life Sciences

Châtillon, France, le 5 mai (22 :30 CEST) 2025 DBV Technologies participera à la conférence Citizens JMP Life Sciences DBV Technologies (Euronext : DBV – ISIN : FR0010417345 – Nasdaq Stock Market : DBVT), société biopharmaceutique en phase clinique, …

ArtsPR  awarded Community Outreach Ticket Subsidy by NJPAC in 2025

ArtsPR awarded Community Outreach Ticket Subsidy by NJPAC in 2025

NEWARK, NJ, UNITED STATES, May 5, 2025 /⁨EINPresswire.com⁩/ -- "CONGRATULATIONS !!!" "Your organization has been selected for the New Jersey Performing Arts Center ticket subsidy program founded by Allen and Joan Bildner, also funded by Dana …

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab

OSE Immunotherapeutics Announces >90% of Responders Maintained Symptomatic Remission Through Extension Period on Lusvertikimab Lusvertikimab well tolerated over the 24-week additional treatment period. Oral presentation at DDW 2025 of clinical data from …

OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab

OSE Immunotherapeutics annonce que plus de 90% des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab

OSE Immunotherapeutics annonce que plus de 90 % des patients répondeurs ont maintenu une rémission symptomatique pendant la période d’extension sous Lusvertikimab Bonne tolérance de Lusvertikimab pendant les 24 semaines supplémentaires de traitement. …

AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting

AB Science will present new data from masitinib clinical program in ALS in two presentations at the 2025 ENCALS Annual Meeting

PRESS RELEASE AB SCIENCE TO PRESENT NEW DATA FROM MASITINIB CLINICAL PROGRAM IN AMYOTROPHIC LATERAL SCLEROSIS IN TWO PRESENTATIONS AT THE 2025 ENCALS ANNUAL MEETING MASITINIB REDUCES SERUM NEUROFILAMENT LIGHT CHAIN (NFL) LEVELS, SUGGESTING THAT IT HAS …

AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA

AB Science présentera lors de la réunion annuelle de l’ENCALS en 2025 de nouvelles données issues du programme de développement clinique du masitinib dans la SLA

COMMUNIQUE DE PRESSE AB SCIENCE PRÉSENTERA LORS DE LA RÉUNION ANNUELLE DE L'ENCALS EN 2025 DE NOUVELLES DONNÉES ISSUES DU PROGRAMME DE DEVELOPPEMENT CLINIQUE DU MASITINIB DANS LA SCLÉROSE LATÉRALE AMYOTROPHIQUE LE MASITINIB RÉDUIT LA CONCENTRATION SERIQUE …

RUBIS: Q1 2025 trading update - Continued strong operating performance of Rubis’ diversified business model

RUBIS: Q1 2025 trading update - Continued strong operating performance of Rubis’ diversified business model

Paris, 5 May 2025, 5:45pm Energy Distribution Retail …

RUBIS: Activité du premier trimestre 2025 - Nouveau trimestre de performance opérationnelle solide du modèle diversifié

RUBIS: Activité du premier trimestre 2025 - Nouveau trimestre de performance opérationnelle solide du modèle diversifié

Paris, le 5 mai 2025, 17h45 Distribution d'énergies Retail …

Coface : Coface records a good start to the year with net income of €62.1m, for an RoATE of 12.7%

Coface : Coface records a good start to the year with net income of €62.1m, for an RoATE of 12.7%

Coface records a good start to the year with net income of €62.1m, for an RoATE of 12.7% Paris, 5 May 2025 – 17.35 Turnover: €473m, up 2.0% at constant FX and perimeter Trade credit insurance revenue up 1.2%; client activity also increased by 1.2% Client …

Coface : Coface enregistre un bon début d’année avec un résultat net de 62,1 M€, soit un RoATE de 12,7%

Coface : Coface enregistre un bon début d’année avec un résultat net de 62,1 M€, soit un RoATE de 12,7%

Coface enregistre un bon début d’année avec un résultat net de 62,1 M€, soit un RoATE de 12,7% Paris, le 5 mai 2025 – 17h35 Chiffre d’affaires : 473 M€, en hausse de 2,0% à périmètre et taux de change constants Les primes d’assurance-crédit sont en hausse …

EPSA Innovation announces the acquisition of FI Group's international activities and becomes the global leader in innovation financing

EPSA Innovation announces the acquisition of FI Group's international activities and becomes the global leader in innovation financing

EPSA, a specialist in financial, operational and environmental performance, is a major player in innovation financing in France and Europe. EPSA Innovation, with €82 million revenues in this business segment (50% in France and 50% internationally), is …

Virtune announces change of Index Provider

Virtune announces change of Index Provider

Stockholm, 5 May 2025 - Virtune announces that as of May 12, 2025, the index provider for Virtune’s existing index ETPs will change to MarketVector IndexesTM (“MarketVector”). In addition, reference prices from MarketVector will be used for Virtune’s other …

Virtune meddelar byte av Indexleverantör

Virtune meddelar byte av Indexleverantör

Stockholm, 5 maj 2025 - Virtune meddelar att från och med den 12 maj 2025 kommer indexleverantören för Virtunes existerande index-ETP:er att ändras till MarketVector IndexesTM (“MarketVector”). Därtill så kommer referenspriser från MarketVector att …

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics Announces Status of Common Share Repurchase Program Disclosure of Transactions in Own Shares – Period from Apr 28, 2025 to May 2, 2025 AMSTERDAM – May 5, 2025 -- STMicroelectronics N.V. (the “Company” or “STMicroelectronics”), a global …

Trustable présente son offre d’évaluation cyber des tiers

Trustable présente son offre d’évaluation cyber des tiers

L’éditeur Trustable annonce la disponibilité de sa solution Saas d’évaluation cyber des tiers. La réglementation DORA impose aux institutions financières de renforcer la gestion des risques tiers en s’assurant que leurs prestataires respectent des …

Atos Announces SecureHorizons NIS2 Compliance Manager Application Powered by the ServiceNow Platform to Streamline Cybersecurity Efforts

Atos Announces SecureHorizons NIS2 Compliance Manager Application Powered by the ServiceNow Platform to Streamline Cybersecurity Efforts

Press Release Atos Announces SecureHorizons NIS2 Compliance Manager Application Powered by the ServiceNow Platform to Streamline Cybersecurity Efforts First-to-market Application Helps Customers Achieve NIS2 Compliance Through Streamlined, Automated …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service